Clinical trial Recruiting at 1 site Observational Ages 3 to 14

Exploring genetic factors in childhood asthma

Official title: Association Between Cytokines Gene Single Nucleotide Polymorphisms and Type 2 Inflammatory Asthma in Children

Run by Guangzhou Institute of Respiratory Disease · NCT06840717 · Data updated 2026-11-12

This study is trying to see if certain genetic factors are linked to asthma in children to help find better treatments and prevention methods.

Quick facts

Study typeObservational
Ages3 Years to 14 Years
SexAll
Enrollment300 (estimated)
SponsorGuangzhou Institute of Respiratory Disease
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJanuary 30, 2024
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedFebruary 21, 2025
Trial IDNCT06840717 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children diagnosed with asthma who meet specific criteria for type 2 inflammation.

Probably not a fit

Patients with other respiratory diseases or those who have taken certain medications prior to the study may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the association between genetic single nucleotide polymorphisms (SNPs) and type 2 inflammation-related asthma in children. It involves analyzing SNPs, lung function, and type 2 inflammation indicators in children diagnosed with asthma, comparing them to healthy controls. The goal is to identify genetic risk factors that may contribute to asthma and to provide insights for personalized treatment and prevention strategies.

Why it matters

Potential benefit: If successful, this study could lead to more tailored and effective treatments for children suffering from type 2 asthma.

How similar studies have gone: Other studies have shown promising results in understanding genetic factors in asthma, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All children with asthma diagnosis accord with the GINA in 2023 edition;
2. Other diseases that could cause wheezing and cough were excluded, such as acute laryngitis, diphtheria, congenital airway abnormalities, and tracheal foreign bodies;
3. In front of the hospital 2 weeks without antibiotics, systemic hormone medication history;
4. There were no other complications, such as congenital heart disease, pneumonia, gastroesophageal reflux disease, muscle dysplasia, etc.

Exclusion Criteria:

1. Children who had taken immunosuppressants, antibiotics and other drugs for a long time before admission;
2. Children with primary immunodeficiency disease;
3. The children and their families failed to cooperate or refused the experimental observation.

Where it's running

  • Guangzhou institute of respiratory disease
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.